RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization (Retracted Article)

被引:410
作者
Lee, KangAe [1 ,2 ]
Zhang, Huafeng [1 ,3 ]
Qian, David Z. [1 ,3 ]
Rey, Sergio [1 ,2 ]
Liu, Jun O. [3 ,4 ]
Semenza, Gregg L. [1 ,2 ,3 ,5 ,6 ,7 ]
机构
[1] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
关键词
cancer; chemotherapy; hypoxia; xenograft; HYPOXIA; ANGIOGENESIS; BINDING;
D O I
10.1073/pnas.0909353106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIF-1 is a heterodimeric transcription factor that mediates adaptive responses to hypoxia and plays critical roles in cancer progression. Using a cell-based screening assay we have identified acriflavine as a drug that binds directly to HIF-1 alpha and HIF-2 alpha and inhibits HIF-1 dimerization and transcriptional activity. Pretreatment of mice bearing prostate cancer xenografts with acriflavine prevented tumor growth and treatment of mice bearing established tumors resulted in growth arrest. Acriflavine treatment inhibited intratumoral expression of angiogenic cytokines, mobilization of angiogenic cells into peripheral blood, and tumor vascularization. These results provide proof of principle that small molecules can inhibit dimerization of HIF-1 and have potent inhibitory effects on tumor growth and vascularization.
引用
收藏
页码:17910 / 17915
页数:6
相关论文
共 16 条
[1]   Structural basis of ARNT PAS-B dimerization: Use of a common beta-sheet interface for hetero- and homodimerization [J].
Card, PB ;
Erbel, PJA ;
Gardner, KH .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 353 (03) :664-677
[2]   Inhibition of lipopolysaccharide-induced I-κB degradation and tumor necrosis factor-α expression by acriflavine, an antimicrobial agent [J].
Choi, SH ;
Cho, JY ;
Chung, YS ;
Hong, EK ;
Han, YB ;
Kim, SG .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 2000, 22 (10) :775-787
[3]   Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response [J].
Dewhirst, Mark W. ;
Cao, Yiting ;
Moeller, Benjamin .
NATURE REVIEWS CANCER, 2008, 8 (06) :425-437
[4]   HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion [J].
Du, Rose ;
Lu, Kan V. ;
Petritsch, Claudia ;
Liu, Patty ;
Ganss, Ruth ;
Passegue, Emmanuelle ;
Song, Hanqiu ;
VandenBerg, Scott ;
Johnson, Randall S. ;
Werb, Zena ;
Bergers, Gabriele .
CANCER CELL, 2008, 13 (03) :206-220
[5]   HIF-dependent antitumorigenic effect of antioxidants in vivo [J].
Gao, Ping ;
Zhang, Huafeng ;
Dinavahi, Ramani ;
Li, Feng ;
Xiang, Yan ;
Raman, Venu ;
Bhujwalla, Zaver M. ;
Felsher, Dean W. ;
Cheng, Linzhao ;
Pevsner, Jonathan ;
Lee, Linda A. ;
Semenza, Gregg L. ;
Dang, Chi V. .
CANCER CELL, 2007, 12 (03) :230-238
[6]  
GOLDIE H, 1959, JNCI-J NATL CANCER I, V23, P841
[7]   Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway [J].
Isaacs, JS ;
Jung, YJ ;
Mimnaugh, EG ;
Martinez, A ;
Cuttitta, F ;
Neckers, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) :29936-29944
[8]   Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 [J].
Jiang, BH ;
Rue, E ;
Wang, GL ;
Roe, R ;
Semenza, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17771-17778
[9]   Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway [J].
Kaelin, William G., Jr. ;
Ratcliffe, Peter J. .
MOLECULAR CELL, 2008, 30 (04) :393-402
[10]   Targeting hypoxia cell signaling for cancer therapy [J].
Melillo, Giovanni .
CANCER AND METASTASIS REVIEWS, 2007, 26 (02) :341-352